ClinicalTrials.gg
RecruitingNCT07770438THP-2 Aim 3Updated Sep 15, 2026

Evaluating the Effects of Reproductive Health Training on Provider Behavior - Aim 3

An interventional study of Afrocentric Sexual and Reproductive Health Curriculum in Sexual and Reproductive Health, Health Knowledge, Attitudes, Practice and Provider Behavior, sponsored by University of Minnesota. Recruiting at 3 sites in Tanzania. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-15.

Sponsored by University of Minnesota · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Sep 2026; still recruiting 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
650
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This study will evaluate the real-world effectiveness of a four-day Afrocentric sexual and reproductive health curriculum for health professional students in Tanzania.

Medical, nursing, and midwifery students from the State University of Zanzibar, Kilimanjaro Christian University, and the University of Dodoma will receive the curriculum. The curriculum covers sexual health across the lifespan, sexual dysfunctions, key populations, sexual violence, clinical skills training, ethics, policy writing, community resources, and cultural considerations.

Student outcomes will be assessed using surveys at baseline, immediately after the curriculum, and at 3-month and 12-month follow-up to examine changes in sexual health knowledge, attitudes, and sexual history and counseling skills.

Read the detailed description

Training for Health Professionals 2 Aim 3 is designed to evaluate the real-world effectiveness and feasibility of disseminating an Afrocentric sexual and reproductive health curriculum for health professional students in Tanzania. The study builds on prior Training for Health Professionals work, including a previous randomized controlled trial that showed improvements in sexual and reproductive health knowledge, attitudes, and clinical skills among health care students.

This Phase IV implementation study will be conducted at three institutions in Tanzania: the State University of Zanzibar, Kilimanjaro Christian University, and the University of Dodoma. The study will enroll medical, nursing, and midwifery students who are current pre-final year students at one of the participating institutions.

Participants will receive a four-day Afrocentric comprehensive sexual and reproductive health curriculum. The curriculum covers sexual health across the lifespan and male and female sexual dysfunctions on Day 1; key populations, including LGBT persons and sex workers, and sexual violence on Day 2; clinical skills training, ethics, and policy writing on Day 3; and community resources and cultural considerations on Day 4.

Participants will complete study surveys at baseline, immediately after the intervention, and at 3-month and 12-month follow-up. The surveys will assess sexual health knowledge, attitudes, and sexual history and counseling skills. Faculty involved in delivering the curriculum will also complete post-training evaluations assessing their knowledge, comfort, and skills in teaching the curriculum.

The study will evaluate whether participants increase and retain sexual health knowledge, attitudes, and skills after participating in the curriculum in a real-world educational setting. The study will also assess implementation fidelity and faculty training outcomes to inform future dissemination of the curriculum.

02

Conditions studied

  • Sexual and Reproductive Health
  • Health Knowledge, Attitudes, Practice
  • Provider Behavior
  • Health Education
  • Sexual Health

Keywords

  • THP-2
  • Sexual and reproductive health
  • Training for Health Professionals
  • Medical students
  • Afrocentric curriculum
  • Sexual health curriculum
03

In context

Behavior

1,573 studies on the registry are indexed under Behavior; 313 are open to participants now.

This study's planned enrollment of 650 is above the median of 120 across 1,197 interventional studies indexed under Behavior.

Browse Behavior studies →

Lead sponsor

University of Minnesota is the lead sponsor of 1,216 studies on the registry; 197 are open to participants now.

Of its 136 completed or terminated interventional studies of FDA-regulated products, 95 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Current pre-final year student at the State University of Zanzibar, Kilimanjaro Christian University, or the University of Dodoma in midwifery, nursing, or medicine
  • Able to attend the full 4-day training
  • Fluent in English and Kiswahili
  • Willing to volunteer to complete all evaluation procedures

Exclusion criteria

Exclusion Criteria:

  • Unable to attend all days of the seminar at SUZA, KCMC, or UDOM
  • Unable to be on the SUZA, KCMC, or UDOM campus for the follow-up dates
  • Expresses reservations about attending, including religious objections
  • Expresses fear of violence due to attending, including fear from a spouse or relative
  • Prior exposure to the Training for Health Professionals curriculum or either of the previous pilots
  • Younger than 18 years of age
  • Non-English speaker
  • Unable to read
  • Employee of the researcher
  • Prisoner
  • Adult lacking capacity to consent or with diminished capacity to consent
  • Active member of the military or DoD personnel
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
650 participants (estimated)

Study arms

  • Experimental
    Afrocentric Sexual and Reproductive Health Curriculum

    Participants will receive a four-day Afrocentric comprehensive sexual and reproductive health curriculum at SUZA, KCMC, or UDOM in Tanzania. Outcomes will be assessed using surveys at baseline, immediately after the curriculum, and at 3- and 12-month follow-up.

    Behavioral: Afrocentric Sexual and Reproductive Health Curriculum

Interventions

  • BehavioralAfrocentric Sexual and Reproductive Health Curriculum

    The intervention is a four-day Afrocentric comprehensive sexual and reproductive health curriculum. It covers sexual health across the lifespan, male and female sexual dysfunctions, key populations including LGBT persons and sex workers, sexual violence, clinical skills training, ethics, policy writing, community resources, and cultural considerations.

    Also known as: Training for Health Professionals Curriculum

06

What researchers measure

Primary outcomes

  1. Change in Sexual and Reproductive Health Knowledge

    Change in sexual and reproductive health knowledge will be assessed using participant survey responses collected before the curriculum, immediately after the curriculum, and at 3-month and 12-month follow-up.

    Time frame: Baseline, immediately post-intervention, 3 months, and 12 months

  2. Change in Sexual and Reproductive Health Attitudes

    Change in attitudes related to sexual and reproductive health care will be assessed using participant survey responses collected before the curriculum, immediately after the curriculum, and at 3-month and 12-month follow-up.

    Time frame: Baseline, immediately post-intervention, 3 months, and 12 months

  3. Change in Sexual History Taking and Counseling Skills

    Change in sexual history taking and counseling skills will be assessed using participant survey responses collected before the curriculum, immediately after the curriculum, and at 3-month and 12-month follow-up.

    Time frame: Baseline, immediately post-intervention, 3 months, and 12 months

07

Study locations

3 of 3 sites recruiting
  • University of Dodoma
    Dodoma, Tanzania
    Recruiting
    • B. R. Simon Rosser, PhD · Contactrosser@umn.edu · 612-624-0358
    • Dickson Mkoka, PhD · Principal investigator
  • Kilimanjaro Christian University
    Moshi, Tanzania
    Recruiting
    • B. R. Simon Rosser, PhD · Contactrosser@umn.edu · 612-624-0358
    • Dickson Mkoka, PhD · Principal investigator
  • State University of Zanzibar
    Zanzibar, Tanzania
    Recruiting
    • B. R. Simon Rosser, PhD · Contactrosser@umn.edu · 612-624-0358
    • Dickson Mkoka, PhD · Principal investigator
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Aug 2027, 11 months after the start.

Of 741 non-industry interventional studies with no phase under Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 32. This study's planned 11 months is below that.

Counting every sponsor, half of 757 studies reached it within 13 months; a quarter within 5 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 12, 2026
First posted
Aug 18, 2026
StartActual
Sep 14, 2026
Primary completionEst.
Aug 17, 2027
CompletionEst.
Aug 17, 2027
Last update
Sep 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07770438
Responsible party
Sponsor
First posted
Aug 18, 2026
Start date
Sep 14, 2026
Primary completion
Aug 17, 2027 (estimated)
Completion
Aug 17, 2027 (estimated)
Last update
Sep 15, 2026

Study contacts

Koua A
Contact
herxx159@umn.edu
612-626-3500
B. R. Simon Rosser, PhD
Contact
rosser@umn.edu
612-624-0358
B. R. Simon Rosser, PhD
principal investigator · University of Minnesota

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion